Cubist Systematic Strategies, LLC Bio Rad Laboratories, Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$304.11 - $351.99 $6.17 Million - $7.14 Million	-20,284 Reduced 99.36%	130 $44,000
Q4 2023 Feb 14, 2024	BUY	$269.37 - $365.04 $4.99 Million - $6.77 Million	18,543 Added 991.07%	20,414 $6.59 Million
Q3 2023 Nov 14, 2023	SELL	$350.25 - $422.63 $941,121 - $1.14 Million	-2,687 Reduced 58.95%	1,871 $670,000
Q2 2023 Aug 14, 2023	SELL	$359.49 - $486.4 $4.54 Million - $6.14 Million	-12,617 Reduced 73.46%	4,558 $1.73 Million
Q1 2023 May 15, 2023	SELL	$418.69 - $503.0 $145,285 - $174,541	-347 Reduced 1.98%	17,175 $8.23 Million
Q4 2022 Feb 14, 2023	SELL	$351.71 - $456.01 $1.44 Million - $1.87 Million	-4,098 Reduced 18.95%	17,522 $7.37 Million
Q3 2022 Nov 14, 2022	BUY	$412.59 - $563.26 $3.97 Million - $5.43 Million	9,633 Added 80.36%	21,620 $9.02 Million
Q2 2022 Aug 15, 2022	SELL	$463.67 - $597.16 $6.09 Million - $7.84 Million	-13,131 Reduced 52.28%	11,987 $5.93 Million
Q1 2022 May 16, 2022	BUY	$524.57 - $735.42 $6.63 Million - $9.3 Million	12,647 Added 101.41%	25,118 $14.1 Million
Q4 2021 Feb 14, 2022	BUY	$708.84 - $794.68 $4.36 Million - $4.89 Million	6,153 Added 97.39%	12,471 $9.42 Million
Q3 2021 Nov 15, 2021	BUY	$657.71 - $825.77 $1.06 Million - $1.33 Million	1,610 Added 34.2%	6,318 $4.71 Million
Q2 2021 Aug 16, 2021	SELL	$576.64 - $649.04 $3.94 Million - $4.43 Million	-6,826 Reduced 59.18%	4,708 $3.03 Million
Q1 2021 May 17, 2021	BUY	$547.01 - $662.35 $3.34 Million - $4.04 Million	6,105 Added 112.45%	11,534 $6.59 Million
Q4 2020 Feb 16, 2021	BUY	$510.68 - $643.45 $1.5 Million - $1.88 Million	2,929 Added 117.16%	5,429 $3.17 Million
Q3 2020 Nov 16, 2020	SELL	$454.43 - $535.6 $3.52 Million - $4.15 Million	-7,755 Reduced 75.62%	2,500 $1.29 Million
Q2 2020 Aug 14, 2020	BUY	$334.87 - $493.06 $485,896 - $715,430	1,451 Added 16.48%	10,255 $4.63 Million
Q1 2020 May 15, 2020	BUY	$320.01 - $409.07 $2.1 Million - $2.68 Million	6,552 Added 290.94%	8,804 $3.09 Million
Q4 2019 Feb 14, 2020	SELL	$319.73 - $374.2 $1.89 Million - $2.22 Million	-5,921 Reduced 72.45%	2,252 $833,000
Q3 2019 Nov 14, 2019	SELL	$304.55 - $345.24 $2.26 Million - $2.57 Million	-7,433 Reduced 47.63%	8,173 $2.72 Million
Q2 2019 Aug 14, 2019	BUY	$286.93 - $312.59 $3.14 Million - $3.42 Million	10,947 Added 234.96%	15,606 $4.88 Million
Q1 2019 May 15, 2019	BUY	$224.3 - $317.41 $572,862 - $810,665	2,554 Added 121.33%	4,659 $1.42 Million
Q4 2018 Feb 14, 2019	BUY	$220.1 - $309.0 $419,290 - $588,645	1,905 Added 952.5%	2,105 $489,000
Q3 2018 Nov 14, 2018	SELL	$289.28 - $326.15 $115,711 - $130,459	-400 Reduced 66.67%	200 $63,000
Q2 2018 Aug 14, 2018	BUY	$244.1 - $303.88 $32,465 - $40,416	133 Added 28.48%	600 $173,000
Q1 2018 May 15, 2018	SELL	$233.97 - $274.11 $1.16 Million - $1.36 Million	-4,945 Reduced 91.37%	467 $117,000
Q4 2017 Feb 14, 2018	BUY	$216.94 - $271.3 $563,393 - $704,566	2,597 Added 92.26%	5,412 $1.29 Million
Q3 2017 Nov 14, 2017	BUY	$212.27 - $242.28 $597,540 - $682,018	2,815	2,815 $626,000

Others Institutions Holding BIO

# of Institutions

457

Shares Held

18.2M

Call Options Held

19.5K

Put Options Held

13.9K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.37B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account